Clinical Trial Update: BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for BB-101 in treating diabetic foot ulcers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• BB-101

Snippet

Sponsor: Blue Blood Biotech Corp. | Conditions: Diabetic Foot Ulcer | Phase 1 | Status: COMPLETED